clinical trial · NCT07098585
To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.
Humanis Saglık Anonim Sirketi·phase1·completed·n = 48
Attention Deficit/Hyperactivity Disorder (ADHD)Lisdexamfetamine capsuleElvanse® (Lisdexamfetamine dimesylate capsules, hard)
brief summary
An open label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, single dose oral bioequivalence study in healthy adult human subjects under fasting conditions.
started
May 26, 2025
primary completion
Jun 6, 2025
completion
Jul 17, 2025
last updated
Aug 1, 2025
official title
An Open Label, Randomized, Two-period, Two-treatment, Two-sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study in Healthy Adult Human Subjects Under Fasting Conditions.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol